Cargando…

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research

Detalles Bibliográficos
Autores principales: Mark, D, Middelkoop, K, Roux, S, Gray, G, Mlisana, K, Nchabaleng, M, Churchyard, G, De Bruyn, G, Latka, M, Magagula, D, Kublin, J, Allen, M, Bekker, L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767709/
http://dx.doi.org/10.1186/1742-4690-6-S3-P214
_version_ 1782173358118404096
author Mark, D
Middelkoop, K
Roux, S
Gray, G
Mlisana, K
Nchabaleng, M
Churchyard, G
De Bruyn, G
Latka, M
Magagula, D
Kublin, J
Allen, M
Bekker, L
author_facet Mark, D
Middelkoop, K
Roux, S
Gray, G
Mlisana, K
Nchabaleng, M
Churchyard, G
De Bruyn, G
Latka, M
Magagula, D
Kublin, J
Allen, M
Bekker, L
author_sort Mark, D
collection PubMed
description
format Text
id pubmed-2767709
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27677092009-10-28 P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research Mark, D Middelkoop, K Roux, S Gray, G Mlisana, K Nchabaleng, M Churchyard, G De Bruyn, G Latka, M Magagula, D Kublin, J Allen, M Bekker, L Retrovirology Poster Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767709/ http://dx.doi.org/10.1186/1742-4690-6-S3-P214 Text en Copyright © 2009 Mark et al; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Mark, D
Middelkoop, K
Roux, S
Gray, G
Mlisana, K
Nchabaleng, M
Churchyard, G
De Bruyn, G
Latka, M
Magagula, D
Kublin, J
Allen, M
Bekker, L
P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
title P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
title_full P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
title_fullStr P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
title_full_unstemmed P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
title_short P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
title_sort p15-13. hvtn 503(phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767709/
http://dx.doi.org/10.1186/1742-4690-6-S3-P214
work_keys_str_mv AT markd p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT middelkoopk p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT rouxs p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT grayg p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT mlisanak p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT nchabalengm p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT churchyardg p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT debruyng p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT latkam p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT magagulad p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT kublinj p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT allenm p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT bekkerl p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch
AT p1513hvtn503phambilitrialdiscontinuationofenrolmentvaccinationtheimpactontrialparticipantattitudestovaccinetrialsandscientificresearch